Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

NCT02456558 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Asymptomatic HIV Infection

Interventions

DRUG: Intravenous deferiprone
DRUG: Placebo

Sponsor

ApoPharma